The Simple micellar recall now covers 200, 400, and 730 ml. Plus: what a bemotrizinol approval does and does not change. ‌ ‌ ‌ ‌ ‌
Issue 001 The Daily Considered September 4, 2026
skin considered*

Sign up  |  About  |  View online

Global skincare news, weighed

Three bottle sizes, one mercury cream, and a new sunscreen filter

Good morning. Today's issue is built from the wire: two official safety actions you can act on, one regulatory change that will take a while to reach a shelf near you, and a review that quietly argues for boring routines.

As always, the grade sits on the exact claim, never on the brand.

🚨

Safety desk

Simple micellar-water recall expands to 200, 400, and 730 ml (4 min read)

A · Strong for this claim

The U.K. Office for Product Safety and Standards widened the recall from the 730 ml bottle to listed batches of the 200 ml and 400 ml sizes over possible microbial contamination. Check the batch code against the official annex; bottles not on the list are not recalled.

FDA warns about mercury in La Crema De Rebeca (4 min read)

A · Strong for this claim

FDA laboratory testing found high mercury levels in a skin-lightening cream sold online, undisclosed on the label. Stop using it, and bring the label to a clinician if you have. This is a finding about one named product, not a verdict on every pigment product.

🏛️

Regulation

The U.S. added its first new sunscreen active in decades (5 min read)

A · Strong for this claim

The FDA's final order permits bemotrizinol at concentrations up to 6% in over-the-counter sunscreens. Finished products still depend on manufacturers and compliant formulas, so this changes what can be sold, not what is on shelves today.

What 1.29 million U.S. cosmetic listings do, and do not, mean (4 min read)

FDA reports 16,398 active facility registrations and 1,298,361 product listings under MoCRA as of June 30. Listing is a traceability requirement. It is not approval, and a listed product is not a vetted product.

🔬

Research

Basic routines did meaningful work in dermatology trials (6 min read)

B · Useful human evidence

A 2026 narrative review looked at the nonmedicated vehicle groups in controlled trials for acne, melasma, rosacea, and more, and found meaningful improvement from basics alone. It is not a meta-analysis, and one author disclosed industry fees.

🧭

Weigh a trend

Slugging (Trend verdict)

A · Strong for this claim

Verdict: reasonable, with a Grade A on petrolatum as an occlusive. It is a standard recommendation for dry or irritated skin applied to everyone; the file names who should skip it and how to slug selectively.

Before a laser, peel, or microneedling appointment (Guide 12)

Match the provider's training and the device's authorization to the exact procedure and goal, then ask for realistic outcomes, alternatives, downtime, pigment risk, and a complication plan.

Reply to this email with a question or a correction. Corrections are sent to the same inbox, dated, and appear on the file itself.

The Daily Considered is the free email from Skin Considered. Free. No sponsors in the body of the email. Unsubscribe in one click. Grades are explained in the methodology; every file links its primary sources. This email is educational and is not medical advice.

Unsubscribe  |  Privacy  |  Corrections  |  RSS

© 2026 Skin Considered